Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt

Avascular Necrosis: early-phase trial registry

4 of 25 indexed Avascular Necrosis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #652 of 28,707 conditions by registered trial count.

25 US clinical trials · 4 currently recruiting · #652 of 28,707 conditions by registered trial count

Avascular Necrosis: 25 US clinical trials tracked, 4 recruiting.

Avascular Necrosis is the subject of 25 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Zimmer Biomet, running 9 of these trials.

Enrollment posture brief

Registry condition avascular-necrosis

OPEN 4 | RECR 16% | LATE 1 | EARLY 2 | RANK #652 | SPON 9

Nearest open-share peer: Atrial Flutter (16% recruiting · 25 trials)

Alpha-1 Antitrypsin Deficien48%Alcohol Use40%Acute Lymphocytic Leukemia36%Alcohol-Related Disorders36%Avascular Necrosis (this)16%
Open-enrollment share among volume-matched conditions near Avascular Necrosis

Avascular Necrosis lists 4 open slots (16% of 25 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Avascular Necrosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Avascular Necrosis is recruiting below its size-band peers.

    4 of 25 indexed trials (16%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Avascular Necrosis research.

    Zimmer Biomet accounts for 9 of 25 trials (36%). 12 distinct sponsors appear on at least one study for this condition label.

  3. Typical Avascular Necrosis enrolment sits around 160 participants.

    Median target enrolment is 160 among the 25 trials that report a genuine target (sentinel values excluded). 8 of those (32%) plan for fewer than 100 participants.

  4. Avascular Necrosis research leans observational.

    10 interventional and 15 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 41

Open and recent trials

25 total, page 1 of 1

RECRUITING NA 800 participants

Physica System Total Knee Replacement Registry Study

Limacorporate S.p.a

NCT03048201

RECRUITING 760 participants

Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

Zimmer Biomet

NCT05787821

RECRUITING 300 participants

Perform Humeral System Study

Stryker Trauma and Extremities

NCT05067543

RECRUITING Phase 2 30 participants

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

University of California, Davis

NCT06016634

ACTIVE NOT RECRUITING NA 643 participants

Persona Partial Knee Clinical Outcomes Study

Zimmer Biomet

NCT03034811

ACTIVE NOT RECRUITING NA 313 participants

Insignia™ Hip Stem Outcomes Study

Stryker Orthopaedics

NCT05144191

ACTIVE NOT RECRUITING NA 300 participants

Cemented vs Cementless Persona Keel RCT

Zimmer Biomet

NCT05630053

ACTIVE NOT RECRUITING NA 240 participants

Persona Ti-Nidium Post-Market Clinical Follow-up

Zimmer Biomet

NCT04817969

ACTIVE NOT RECRUITING 200 participants

Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System

Zimmer Biomet

NCT01480440

ACTIVE NOT RECRUITING 165 participants

Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study

Zimmer Biomet

NCT01307384

ACTIVE NOT RECRUITING 160 participants

Database Retrieval for the Comprehensive Shoulder

Zimmer Biomet

NCT03409718

ACTIVE NOT RECRUITING 150 participants

Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur

MicroPort Orthopedics

NCT04301622

ACTIVE NOT RECRUITING 119 participants

A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System

Smith & Nephew

NCT06564636

ACTIVE NOT RECRUITING 100 participants

Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert

MicroPort Orthopedics

NCT07391592

ACTIVE NOT RECRUITING 76 participants

Pyrocarbon Clinical Follow-up Study

Stryker Trauma and Extremities

NCT05049993

ACTIVE NOT RECRUITING NA 53 participants

Sickle Cell Disease (SCD) Bone Pain Study

University of California, Davis

NCT05283148

ACTIVE NOT RECRUITING 22 participants

The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head

The Cleveland Clinic

NCT05706909

COMPLETED NA 1,593 participants

Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement

DePuy Orthopaedics

NCT00306930

COMPLETED 388 participants

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

Biomet Orthopedics

NCT00578994

COMPLETED 231 participants

Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects

Corin

NCT00721994

COMPLETED 149 participants

A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement

Zimmer Biomet

NCT00698152

COMPLETED Phase 4 86 participants

Opioid-Free Shoulder Arthroplasty

OrthoCarolina Research Institute

NCT03540030

COMPLETED 83 participants

Continuum™ Metal Bearing System in Total Hip Arthroplasty

Zimmer Biomet

NCT03382652

COMPLETED 81 participants

Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement

DePuy Orthopaedics

NCT02096198

COMPLETED Phase 1 36 participants

Acetabular Shell Positioning Using Patient Specific Instruments

The Cleveland Clinic

NCT01791738

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Avascular Necrosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Acetabular positioning system Procedure
1 trials
Metal-on-Metal Articulation Device
1 trials
Cormet Hip Resurfacing System Device
1 trials
regional block Drug
1 trials
toradol Drug
1 trials
Oxford® Meniscal Unicompartmental Knee System Device
1 trials
acetaminophen Drug
1 trials
Acetabular cup Device
1 trials

US sites by state

Facility locations filed on Avascular Necrosis trials. A trial with sites in several states counts in each.

California 10 trials
Ohio 7 trials
North Carolina 7 trials
Illinois 7 trials
Colorado 7 trials
Texas 6 trials
Maryland 6 trials
Pennsylvania 5 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Avascular Necrosis page

25 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Avascular Necrosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Zimmer Biomet sponsors the most Avascular Necrosis trials on record, review their full trial history before evaluating a specific study. See Zimmer Biomet's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Avascular Necrosis condition card totals 25 registered trials; most-linked intervention Acetabular positioning system; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.